Advanced Practice Nursing in the Care of Older Adults 1st Edition

Advanced IPractice INursing Iin Ithe ICare Iof IOlder IAdults I1st IEdition ITest IBank

Advanced IPractice INursing Iin Ithe ICare Iof IOlder IAdults I1st IEdition ITest IBank

Chapter I1: IChanges Iwith IAging

Multiple IChoic

Identify Ithe Ichoice Ithat Ibest Icompletes Ithe Istatement Ior Ianswers Ithe Iquestion.

 I            1. IThe Imajor Iimpact Iof Ithe Iphysiological Ichanges Ithat Ioccur Iwith Iaging Iis:

A.           Reduced Iphysiological Ireserve

B.           Reduced Ihomeostatic Imechanisms

C.           Impaired Iimmunological Iresponse

D.           All Iof Ithe Iabove

 I            2. IThe Istrongest Ievidence Iregarding Inormal Iphysiological Iaging Iis Iavailable Ithrough:

A.           Randomized Icontrolled Iclinical Itrials

B.           Cross-sectional Istudies

C.           Longitudinal Istudies

D.           Case Icontrol Istudies

 I            3. IAll Iof Ithe Ifollowing Istatements Iare Itrue Iabout Ilaboratory Ivalues Iin Iolder Iadults Iexcept:

A.           Reference Iranges Iare Ipreferable

B.           Abnormal Ifindings Iare Ioften Idue Ito Iphysiological Iaging

C.           Normal Iranges Imay Inot Ibe Iapplicable Ifor Iolder Iadults

D.           Reference Ivalues Iare Inot Inecessarily Iacceptable Ivalues

 I            4. IBiochemical Iindividuality Iis Ibest Idescribed Ias:

A.           Each Iindividual’s Ivariation Iis Ioften Imuch Igreater Ithan Ithat Iof Ia Ilarger Igroup

B.           The Iunique Ibiochemical Iprofile Iof Ia Iselected Ipopulation

C.           The Itruly I“normal” Iindividual—falling Iwithin Iaverage Irange

D.           Each Iindividual’s Ivariation Iis Ioften Imuch Ismaller Ithan Ithat Iof Ia Ilarger Igroup

 I            5. IPolypharmacy Iis Ibest Idescribed Ias Itaking:

A.           More Ithan Inine Imedications Iper Iday

B.           More Ithan Ifive Imedications Iper Iday

C.           Even Ia Isingle Imedication Iif Ithere Iis Inot Ia Iclear Iindication Ifor Iits Iuse

D.           When Ia Idrug Iis Igiven Ito Itreat Ithe Iside Ieffect Iof Ianother Idrug

 I            6. IPharmacokinetic Ichanges Iwith Iaging Iis Ireflective Iof:

A.           What Ithe Idrug Idoes Ito Ithe Ibody

B.           What Ithe Ibody Idoes Ito Ithe Idrug

C.           The Ieffect Iat Ithe Isite Iof Iaction Iand Ithe Itime Iand Iintensity Iof Ithe Idrug

D.           The Iside Ieffects Icommonly Iassociated Iwith Ithe Idrug

 I            7. IAll Ithe Ifollowing Istatements Iare Ifalse Iabout Idrug Iabsorption Iexcept:

A.           Antacids Iincrease Ithe Ibioavailability Iof Idigitalis

B.           Gastric Iacidity Idecreases Iwith Iage

C.           Anticholinergics Iincrease Icolonic Imotility

D.           Underlying Ichronic Idisease Ihas Ilittle Iimpact Ion Idrug Iabsorption

 I            8. IAll Iof Ithe Ifollowing Istatements Iare Itrue Iabout Idrug Idistribution Iin Ithe Ielderly Iexcept:

A.           Drugs Idistributed Iin Iwater Ihave Ilower Iconcentration

B.           Drugs Idistributed Iin Ifat Ihave Iless Iintense, Imore Iprolonged Ieffect

C.           Drugs Ihighly Iprotein Ibound Ihave Igreater Ipotential Ito Icause Ian Iadverse Idrug Ireaction

D.           The Ifastest Iway Ito Ideliver Ia Idrug Ito Ithe Iaction Isite Iis Iby Iinhalation

 I            9. IMen Ihave Ifaster Iand Imore Iefficient Ibiotransformation Iof Idrugs Iand Ithis Iis Ithought Ito Ibe Idue Ito:

A.           Less Iobesity Irates Ithan Iwomen

B.           Prostate Ienlargement

C.           Testosterone

D.           Less Iestrogen Ithan Iwomen

 I        I I10. IThe Icytochrome Ip Isystem Iinvolves Ienzymes Ithat Iare Igenerally:

A.           Inhibited Iby Idrugs

B.           Induced Iby Idrugs

C.           Inhibited Ior Iinduced Iby Idrugs

D.           Associated Iwith Idecreased Iliver Iperfusion

 I        I I11. IA Istatement Inot Ishown Ito Ibe Itrue Iabout Ipharmacodynamics Ichanges Iwith Iaging Iis:

A.           Decreased Isensitivity Ito Ioral Ianticoagulants

B.           Enhanced Isensitivity Ito Icentral Inervous Isystem Idrugs

C.           Drug Iresponsiveness Ican Ibe Iinfluenced Iby Ipatient Iactivity Ilevel

D.           There Iis Ia Idecreased Isensitivity Ito Ibeta Iblockers

 I        I I12. IAtypical Ipresentation Iof Idisease Iin Ithe Ielderly Iis Ireflected Iby Iall Ithe Ifollowing Iexcept:

A.           Infection Iwithout Ifever

B.           Depression Iwithout Idysphoric Imood

C.           Myocardial Iinfarction Iwith Ichest Ipain Iand Idiaphoresis

D.           Cardiac Imanifestations Iof Ithyroid Idisease

 I        I I13. IFunctional Iabilities Iare Ibest Iassessed Iby:

A.           Self-report Iof Ifunction

B.           Observed Iassessment Iof Ifunction

C.           A Icomprehensive Ihead-to-toe Iexamination

D.           Family Ireport Iof Ifunction

Chapter I1: IChanges Iwith IAging IAnswer ISection

MULTIPLE ICHOICE

1.       ANS: ID                   PTS: I1

2.       ANS: IC                    PTS: I1

3.       ANS: IB                    PTS: I1

4.       ANS: ID                   PTS: I1

5.       ANS: IC                    PTS: I1

6.       ANS: IB                    PTS: I1

7.       ANS: ID                   PTS: I1

8.       ANS: IA                   PTS: I1

9.       ANS: IC                    PTS: I1

10.   ANS: IC                    PTS: I1

11.   ANS: IA                   PTS: I1

12.   ANS: IC                    PTS: I1

13.   ANS: IB                    PTS: I1